Formoterol Fumarate
Tier C — Watch / tradeFormoterol Fumarate
Targets:ADRB2
Brand:Eolus, Atimos, Oxeze, Oxis, Broncoral, Foradil Aerolizer, Foradil, Foradil Certihaler, Oxis Turbuhaler, Atock, Perforomist
Indications (approved):Chronic obstructive pulmonary disease, Emphysema, Asthma, Bronchitis
Regional status
Factories producing this API3
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
3 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates6 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Formoterol Fumarate-001 | - | 1-(4-Hydroxy-3-nitrophenyl)ethan-1-one |
| Formoterol Fumarate-002 | - | 1-(4-(Benzyloxy)-3-nitrophenyl)ethanone |
| Formoterol Fumarate-003 | - | 1-(4-(Benzyloxy)-3-nitrophenyl)-2-bromoethanone |
| Formoterol Fumarate-004 | - | (2R*)-N-Benzyl-1-(4-methoxyphenyl)propan-2-amine |
| Formoterol Fumarate-005 | 1199228-78-8 | (2R)-N-Benzyl-1-(4-methoxyphenyl)propan-2-amine hydrogen chloride |
| Formoterol Fumarate-006 | - | 2-[Benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]ethanone |
| Formoterol Fumarate-007 | - | (1R*)-2-[Benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]ethanol |
| Formoterol Fumarate-008 | - | (1R*)-1-[3-Amino-4-(benzyloxy)phenyl]-2-[benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]ethanol |
| Formoterol Fumarate-009 | - | Acido formico |
| Formoterol Fumarate-010 | - | Amide c1 |
| Formoterol Fumarate-011 | - | N-[5-[(1R*)-2-[Benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]-1-hydroxyethyl]-2-(benzyloxy)phenyl]formamide |
| Formoterol Fumarate-012 | - | N-[2-Hydroxy-5-[1(R*)-hydroxy-2-[1(R*)-methyl-2-(4-methoxyphenyl)ethylamino]ethyl]phenyl]formamide |
| Code | CAS No. | Intermediate |
|---|---|---|
| Formoterol Fumarate-013 | 960303-94-0 | N-{5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenyl}formamide |
| Formoterol Fumarate-014 | - | 1-(4-Methoxyphenyl)-2-propanone |
| Formoterol Fumarate-015 | - | 1,2-Ethylenedicarboxylic acid |
| Code | CAS No. | Intermediate |
|---|---|---|
| Formoterol Fumarate-016 | 345288-55-3 | 1-[4-(Benzyloxy)-3-nitrophenyl]-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethanol |
| Formoterol Fumarate-017 | 126587-93-7 | N-[2-(Benzyloxy)-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide |
| Code | CAS No. | Intermediate |
|---|---|---|
| Formoterol Fumarate-018 | 43229-66-9 | 2-[Benzyl[1-(4-methoxyphenyl)propan-2-yl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]ethanone |
| Formoterol Fumarate-019 | 43229-67-0 | 2-[Benzyl[1-(4-methoxyphenyl)propan-2-yl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]ethanol |
| Formoterol Fumarate-020 | - | 1-(4-Methoxyphenyl)-2-benzylaminopropane |
| Formoterol Fumarate-021 | - | 2-[4-(Benzyloxy)-3-nitrophenyl]oxirane |
| Formoterol Fumarate-008 | - | (1R*)-1-[3-Amino-4-(benzyloxy)phenyl]-2-[benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]ethanol |
| Formoterol Fumarate-007 | - | (1R*)-2-[Benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]ethanol |
| Formoterol Fumarate-009 | - | Acido formico |
| Formoterol Fumarate-011 | - | N-[5-[(1R*)-2-[Benzyl[(2R*)-1-(4-methoxyphenyl)propan-2-yl]amino]-1-hydroxyethyl]-2-(benzyloxy)phenyl]formamide |
| Formoterol Fumarate-012 | - | N-[2-Hydroxy-5-[1(R*)-hydroxy-2-[1(R*)-methyl-2-(4-methoxyphenyl)ethylamino]ethyl]phenyl]formamide |
| Code | CAS No. | Intermediate |
|---|---|---|
| Formoterol Fumarate-022 | - | - |
| Formoterol Fumarate-023 | - | - |
| Formoterol Fumarate-024 | - | - |
| Formoterol Fumarate-025 | - | - |
| Code | CAS No. | Intermediate |
|---|---|---|
| Formoterol Fumarate-026 | - | Anisole |
| Formoterol Fumarate-027 | - | 1-Chloro-4-methoxybenzene |
Frequently asked questions
What are the approved indications of Formoterol Fumarate?
Approved indications include: Chronic obstructive pulmonary disease, Emphysema, Asthma, Bronchitis.
When does the Formoterol Fumarate patent expire?
No public expiry year is available for Formoterol Fumarate yet; this page updates once verified.
How many synthesis routes are recorded for Formoterol Fumarate?
6 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Formoterol Fumarate intermediates?
All intermediates in Formoterol Fumarate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Formoterol Fumarate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29